Companion Animal Arthritis Market size was valued at USD 2.9 Billion in 2022 and the total Companion Animal Arthritis Market is expected to grow at a CAGR of 7% from 2023 to 2029, reaching nearly USD 5.5 Billion.Overview
The companion animal arthritis market pertains to a condition that affects companion animals such as cats, dogs, and other exotic animals, causing inflammation in one or more joints due to cartilage wear and tear. Osteoarthritis, the most common type of arthritis in companion animals, frequently affects the hips, knees, and shoulders, and is more common in overweight or injured animals. Symptoms include reluctance to go on walks, difficulty getting up and down, crawling, and restlessness, as well as postural changes induced by spinal issues, thinning limbs from muscular atrophy, excessive licking, biting, or chewing, localized hair loss or inflammation, and low energy. The companion animal arthritis market is expected to grow due to a rise in pet ownership and pet care expenditure worldwide, with the number of US homes with pets and pet care expenditures at an all-time high in 2022, as many pet owners view their pets as family members and invest more time and money in their care. However, the lack of good veterinary care in some countries may limit market growth opportunities. Industry growth is driven by several factors, including the growing companion animal population, the increase in the prevalence of arthritis, the rise in risk factors for the condition, government-supported awareness efforts, and the methods employed by major corporations.To know about the Research Methodology :- Request Free Sample Report
Competitive Landscapes:
The Companion Animal Arthritis market is moderately competitive with a few key players dominating the majority of the market share. Due to the limited availability of products, both new entrants and established players are focused on launching new products to increase their market share. To maintain their market position, leading players are implementing various strategic initiatives such as competitive pricing strategies, partnerships, product and service expansion, sales and marketing initiatives, and mergers & acquisitions. For example, Zoetis received FDA approval in January 2022 for Solentia, a monoclonal antibody injection used to treat osteoarthritis pain in cats. Key players are also enhancing their overall industry presence by launching new manufacturing units. In April 2022, Elanco collaborated with Ginkgo Bioworks to launch a new veterinary company BiomEdit to introduce engineered microbes and probiotics in veterinary care services. Such initiatives by companies and organizations are driving the growth of the Companion Animal Arthritis market. The market is not highly competitive, but the rivalry among key players is intense, leading to a constant need for innovation and strategic initiatives.Companion Animal Arthritis Market Dynamics:
Increasing prevalence of obesity among the companion animals to Drive the Growth of Companion Animal Arthritis Market The prevalence of obesity among companion animals is a significant factor driving the growth of the Companion Animal Arthritis market. Overfeeding and lack of physical activity in pets are the primary reasons for obesity, and pet owners often reward their pets with food, leading to overfeeding. Companion animals confined to houses or small yards without regular exercise are more likely to become overweight. In dogs, the risk of obesity is linked to the obesity of their owners, who may not walk their dogs enough. In cats, neutering increases the risk of obesity because of the lowered basal metabolic rate and reduced inclination to roam. North America has a high prevalence of obesity in dogs, with 56% of dogs and 60% of cats classified as overweight or obese. The increasing prevalence of obesity in companion animals, including horses, is expected to drive the growth of the Companion Animal Arthritis market. Approximately 30% of the general canine population is obese, and 40-45% of dogs aged 5-11 years old weigh higher than normal. The market is expected to witness significant growth during the forecast period due to these factors. Growing demand for Pet Healthcare Insurance to fuel the market growth The rising demand for pet insurance due to growing animal health expenditure is expected to fuel the growth of the Companion Animal Arthritis market during the forecast period. Pet healthcare expenditure, which includes veterinary care, pet insurance policies, pet food, supplies/OTC medication, live animal purchases, and other services such as companion animal diagnostic and treatment services, has significantly increased in recent years. According to the American Pet Products Association (APPA), veterinary expenditure in the US has increased from USD 66.75 billion in 2016 to USD 109.6 billion by 2021. Pet owners in the US spent USD 32.3 billion on vet care and product sales alone in 2021, up from USD 31.4 billion in 2020. This indicates that the number of pet owners investing in pet medical care has consistently risen yearly. The North American Pet Health Insurance Association (NAPHIA) reported that the pet insurance sector in North America exceeded USD 2.83 billion at the end of 2021, with industry growth more than doubling over the past four years (2018-2021). Pet insurance is gaining popularity as it helps pet owners manage the cost of preventive care, acute and chronic illnesses, and emergency medical care costs for their pets. This trend is expected to continue during the forecast period, fuelling the growth of the Companion Animal Arthritis marketCompanion Animal Arthritis Market Segment Analysis:
Based on Animal Type Based on animal type, the market is segmented into dogs, cats and others. In 2021, the global market for pets was dominated by dogs with a share of over 60%, due to their high disease prevalence and rising adoption rates. The increasing dog population in every region is further fuelling market growth, with 45% of American households owning dogs in 2020 and nearly 88 million European households owning pets. The COVID-19 pandemic has also driven people worldwide to adopt companion animals for psychological comfort. The cats' segment is expected to expand at fastest CAGR due to the growing awareness among pet parents about the symptoms of arthritis in their cats. Almost 90% of cats suffer from arthritis, with larger breeds being more prone to osteoarthritis. However, timely diagnosis may be difficult due to cats' natural ability to hide pain, which could hinder early detection. Based on Arthritis Type Based on Arthritis type the market is segmented into Osteoarthritis, Rheumatoid Arthritis and others. In 2022, the Companion Animal Arthritis market was dominated by the osteoarthritis segment, which having a revenue share of over 75.0%. This was due to the high number of companion animals diagnosed with osteoarthritis. According to the American College of Veterinary Surgeons, around 25% of dogs in the United States are prone to developing osteoarthritis. Similarly, cats also suffer from this condition, which leads to clinical signs such as weight loss, depression, and limited mobility. The Veterinary Ireland Journal reported that nearly 40% of cats display these signs, and 90% of older cats develop osteoarthritis. Rheumatoid arthritis segment is expected to grow significantly during the forecast period. Rheumatoid arthritis in dogs is a chronic condition that causes severe pain and inflammation in joints. Although it is less common than osteoarthritis, it still affects small cats and dogs significantly. Canine rheumatoid factor immunologic tests can diagnose rheumatoid arthritis in dogs in veterinary clinics or hospitals. Research studies have indicated that corticosteroids, cyclosporine, and NSAIDs are effective treatments for rheumatoid arthritis in companion animals.By Treatment By treatment, the market is categorised into Exercise, Medical and Others. The Companion Animal Arthritis market is dominated by the medication segment in 2022. This is due to the increasing prevalence of arthritis among pets caused by risk factors such as obesity, age, and nutritional impairments. Veterinary pharmaceutical companies are launching new products such as NSAIDs, opioids, steroids, stem cells, antibodies, and supplements to meet the rising demand for arthritis treatment among pet owners. Supplements are initially prescribed by veterinarians for pets with less obvious symptoms of arthritis, which is also driving the demand for supplements among pet owners. In addition to medication, other treatments such as rehabilitation, lifestyle management, and novel medications are evolving to improve the quality of life for companion animals associated with arthritis. However, when medication fails to manage the arthritis condition in pets, surgical procedures such as joint replacement, joint fusion, and surgical removal of the affected joint are considered. Arthroscopy is a minimally invasive surgical approach that reduces postoperative pain in dogs and cats. Veterinarians also recommend non-medication treatment options such as weight management, environmental modifications, and physical rehabilitation to improve the health and well-being of pets with arthritis.
Based on Distribution Channel The Companion Animal Arthritis market is comprised of various segments Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores and Others. The veterinary hospitals and clinics segment dominated the market in 2022. This is due to the increasing number of veterinary hospitals and clinics with advanced infrastructures that are crucial for pet healthcare. These clinics and hospitals help pet owners understand the proper dosage of arthritis medicine and ensure timely diagnosis, which is important for managing the condition. The growth of the veterinary hospitals and clinics segment is also attributed to the increasing number of veterinary professionals globally. For instance, in Europe, the number of veterinarians was approximately 263 million in 2019, according to the Federation of Veterinarians of Europe. Other distribution channels such as retail pharmacies, online stores, and research institutes are also contributing to the growth of the Companion Animal Arthritis market. With more households owning companion animals, there is an increasing demand for convenient access to pet arthritis supplements and NSAIDs. Retail vet pharmacies offer various brands of oral supplements, NSAIDs, opioids, and essential oils for arthritis treatment in companion animals. Online sales of pet arthritic products have grown significantly during the COVID-19 pandemic as e-commerce platforms have become a convenient and easily accessible platform for purchasing pet medications. The growing demand for arthritis treatment in companion animals has resulted in intense industry rivalry among pharmaceutical companies. As a result, companies are launching new products such as NSAIDs, opioids, steroids, stem cells, antibodies, and supplements to meet the rising demand for arthritis treatment among pet owners. Additionally, other treatments such as rehabilitation, lifestyle management, and novel medications are evolving to improve the quality of life for companion animals associated with arthritis. However, early detection and intervention play a crucial role in managing arthritis in pets, and pet owners should work closely with their veterinarians to ensure that their pets receive the appropriate treatment and care.
Companion Animal Arthritis Market Regional Insights:
By Region the market is segmented into North America, South America, Asia Pacific, Europe & Milled East Africa. According to a report, North America dominated the global Companion Animal Arthritis market in 2022 and is predicted to continue as the fastest-growing segment in the forecast period. The increase in pet adoption, especially dogs and cats, is contributing to the rise in demand for companion animal arthritis treatments in countries like the U.S. and Canada. The availability of treatments due to advancements in veterinary facilities is also driving the growth of this market in North America. In Europe, the presence of major players like Boehringer Ingelheim International GmbH contributed to the region holding the second-largest revenue share in 2022. The Asia Pacific region is expected to have the highest CAGR during the forecast period, mainly due to rising animal healthcare expenditure and disposable income in key markets. The high adoption of companion animals, incidence of parasitic infections, and increasing awareness about the disease in developing countries like India are further boosting the growth of the market in this region. Additionally, a growing number of research activities, funding, and awareness campaigns in the field of veterinary health management are driving the growth of this market.Companion Animal Arthritis Market Scope: Inquiry Before Buying
Companion Animal Arthritis Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: USD 2.9 Billion Forecast Period 2023 to 2029 CAGR: 7% Market Size in 2029: USD 5.5 Billion Segments Covered: by Animal Type 1.Dog 2.Cat 3.Others by Type 1.Osteoarthritis 2.Rheumatoid Arthritis 3.Others by Treatment 1.Medication 2.Exercise 3.Others by Distribution 1.Online Store 2.Pet Supply Store, 3.Veterinary Hospitals 4Clinics Companion Animal Arthritis Market by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Companion Animal Arthritis Market Key Players:
1. Virbac, 2.Dechra Pharmaceuticals plc, 3.Vetoquinol Animal Health Pvt Ltd, 4. Phibro Animal Health Corp 5. Boehringer Ingelheim GmbH, 6.Bayer AG, 7. Ceva Sante Animale 8. Abbott Laboratories 9. Qiagen N.V. 10.Becton, Dickinson and Company 11. Quest Diagnostics, Inc. 12. Hologic, Inc. 13.F. Hoffmann-La Roche 14.Femasys, Inc. 15.Arbor Vita Corporation 16.NURX, Inc. 17.Seegene, Inc. 18.Thermo Fisher Scientific, Inc. 19. bioMérieux SA FAQs: 1] What segments are covered in the Global Companion Animal Arthritis Market report? Ans. The segments covered in the Companion Animal Arthritis report are based on animal type, arthritis type, treatment, distribution channel and region. 2] Which region is expected to hold the highest share in the Global Companion Animal Arthritis Market during the forecast period? Ans. The North America region is expected to hold the highest share of the Companion Animal Arthritis market during the forecast period. 3] What is the market size of the Global Companion Animal Arthritis by 2029? Ans. The market size of the Companion Animal Arthritis by 2029 is expected to reach US$ 5.5 Bn. 4] What is the forecast period for the Global Companion Animal Arthritis Market? Ans. The forecast period for the Companion Animal Arthritis market is 2023-2029. 5] What was the market size of the Global Companion Animal Arthritis in 2021? Ans. The market size of the Companion Animal Arthritis in 2022 was valued at US$ 2.1 Bn.
1. Companion Animal Arthritis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Companion Animal Arthritis Market: Dynamics 2.1. Companion Animal Arthritis Market Trends by Region 2.1.1. North America Companion Animal Arthritis Market Trends 2.1.2. Europe Companion Animal Arthritis Market Trends 2.1.3. Asia Pacific Companion Animal Arthritis Market Trends 2.1.4. Middle East and Africa Companion Animal Arthritis Market Trends 2.1.5. South America Companion Animal Arthritis Market Trends 2.2. Companion Animal Arthritis Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Companion Animal Arthritis Market Drivers 2.2.1.2. North America Companion Animal Arthritis Market Restraints 2.2.1.3. North America Companion Animal Arthritis Market Opportunities 2.2.1.4. North America Companion Animal Arthritis Market Challenges 2.2.2. Europe 2.2.2.1. Europe Companion Animal Arthritis Market Drivers 2.2.2.2. Europe Companion Animal Arthritis Market Restraints 2.2.2.3. Europe Companion Animal Arthritis Market Opportunities 2.2.2.4. Europe Companion Animal Arthritis Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Companion Animal Arthritis Market Drivers 2.2.3.2. Asia Pacific Companion Animal Arthritis Market Restraints 2.2.3.3. Asia Pacific Companion Animal Arthritis Market Opportunities 2.2.3.4. Asia Pacific Companion Animal Arthritis Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Companion Animal Arthritis Market Drivers 2.2.4.2. Middle East and Africa Companion Animal Arthritis Market Restraints 2.2.4.3. Middle East and Africa Companion Animal Arthritis Market Opportunities 2.2.4.4. Middle East and Africa Companion Animal Arthritis Market Challenges 2.2.5. South America 2.2.5.1. South America Companion Animal Arthritis Market Drivers 2.2.5.2. South America Companion Animal Arthritis Market Restraints 2.2.5.3. South America Companion Animal Arthritis Market Opportunities 2.2.5.4. South America Companion Animal Arthritis Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Companion Animal Arthritis Industry 2.8. Analysis of Government Schemes and Initiatives For Companion Animal Arthritis Industry 2.9. Companion Animal Arthritis Market Trade Analysis 2.10. The Global Pandemic Impact on Companion Animal Arthritis Market 3. Companion Animal Arthritis Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 3.1.1. Dog 3.1.2. Cat 3.1.3. Others 3.2. Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 3.2.1. Osteoarthritis 3.2.2. Rheumatoid Arthritis 3.2.3. Others 3.3. Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 3.3.1. Medication 3.3.2. Exercise 3.3.3. Others 3.4. Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 3.4.1. Online Store 3.4.2. Pet Supply Store, 3.4.3. Veterinary Hospitals 3.4.4. Clinics 3.5. Companion Animal Arthritis Market Size and Forecast, by Region (2022-2029) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Companion Animal Arthritis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 4.1.1. Dog 4.1.2. Cat 4.1.3. Others 4.2. North America Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 4.2.1. Osteoarthritis 4.2.2. Rheumatoid Arthritis 4.2.3. Others 4.3. North America Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 4.3.1. Medication 4.3.2. Exercise 4.3.3. Others 4.4. North America Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 4.4.1. Online Store 4.4.2. Pet Supply Store, 4.4.3. Veterinary Hospitals 4.4.4. Clinics 4.7. North America Companion Animal Arthritis Market Size and Forecast, by Country (2022-2029) 4.5.1. United States 4.5.1.1. United States Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 4.5.1.1.1. Dog 4.5.1.1.2. Cat 4.5.1.1.3. Others 4.5.1.2. United States Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 4.5.1.2.1. Osteoarthritis 4.5.1.2.2. Rheumatoid Arthritis 4.5.1.2.3. Others 4.5.1.3. United States Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 4.5.1.3.1. Medication 4.5.1.3.2. Exercise 4.5.1.3.3. Others 4.5.1.4. United States Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 4.5.1.4.1. Online Store 4.5.1.4.2. Pet Supply Store, 4.5.1.4.3. Veterinary Hospitals 4.5.1.4.4. Clinics 4.5.2. Canada 4.5.2.1. Canada Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 4.5.2.1.1. Dog 4.5.2.1.2. Cat 4.5.2.1.3. Others 4.5.2.2. Canada Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 4.5.2.2.1. Osteoarthritis 4.5.2.2.2. Rheumatoid Arthritis 4.5.2.2.3. Others 4.5.2.3. Canada Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 4.5.2.3.1. Medication 4.5.2.3.2. Exercise 4.5.2.3.3. Others 4.5.2.4. Canada Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 4.5.2.4.1. Online Store 4.5.2.4.2. Pet Supply Store, 4.5.2.4.3. Veterinary Hospitals 4.5.2.4.4. Clinics 4.5.3. Mexico 4.5.3.1. Mexico Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 4.5.3.1.1. Dog 4.5.3.1.2. Cat 4.5.3.1.3. Others 4.5.3.2. Mexico Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 4.5.3.2.1. Osteoarthritis 4.5.3.2.2. Rheumatoid Arthritis 4.5.3.2.3. Others 4.5.3.3. Mexico Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 4.5.3.3.1. Medication 4.5.3.3.2. Exercise 4.5.3.3.3. Others 4.5.3.4. Mexico Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 4.5.3.4.1. Online Store 4.5.3.4.2. Pet Supply Store, 4.5.3.4.3. Veterinary Hospitals 4.5.3.4.4. Clinics 5. Europe Companion Animal Arthritis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.2. Europe Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.3. Europe Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.4. Europe Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5. Europe Companion Animal Arthritis Market Size and Forecast, by Country (2022-2029) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.1.2. United Kingdom Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.1.3. United Kingdom Companion Animal Arthritis Market Size and Forecast, by Treatment(2022-2029) 5.5.1.4. United Kingdom Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.2. France 5.5.2.1. France Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.2.2. France Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.2.3. France Companion Animal Arthritis Market Size and Forecast, by Treatment(2022-2029) 5.5.2.4. France Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.3. Germany 5.5.3.1. Germany Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.3.2. Germany Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.3.3. Germany Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.5.3.4. Germany Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.4. Italy 5.5.4.1. Italy Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.4.2. Italy Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.4.3. Italy Companion Animal Arthritis Market Size and Forecast, by Treatment(2022-2029) 5.5.4.4. Italy Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.5. Spain 5.5.5.1. Spain Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.5.2. Spain Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.5.3. Spain Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.5.5.4. Spain Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.6. Sweden 5.5.6.1. Sweden Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.6.2. Sweden Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.6.3. Sweden Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.5.6.4. Sweden Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.7. Austria 5.5.7.1. Austria Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.7.2. Austria Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.7.3. Austria Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.5.7.4. Austria Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 5.5.8.2. Rest of Europe Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 5.5.8.3. Rest of Europe Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 5.5.8.4. Rest of Europe Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6. Asia Pacific Companion Animal Arthritis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.2. Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.3. Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.4. Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5. Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Country (2022-2029) 6.7.1. China 6.5.1.1. China Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.1.2. China Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.1.3. China Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.1.4. China Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.2. S Korea 6.5.2.1. S Korea Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.2.2. S Korea Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.2.3. S Korea Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.2.4. S Korea Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.3. Japan 6.5.3.1. Japan Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.3.2. Japan Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.3.3. Japan Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.3.4. Japan Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.4. India 6.5.4.1. India Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.4.2. India Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.4.3. India Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.4.4. India Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.5. Australia 6.5.5.1. Australia Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.5.2. Australia Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.5.3. Australia Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.5.4. Australia Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.6. Indonesia 6.5.6.1. Indonesia Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.6.2. Indonesia Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.6.3. Indonesia Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.6.4. Indonesia Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.7. Malaysia 6.5.7.1. Malaysia Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.7.2. Malaysia Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.7.3. Malaysia Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.7.4. Malaysia Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.8. Vietnam 6.5.8.1. Vietnam Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.8.2. Vietnam Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.8.3. Vietnam Companion Animal Arthritis Market Size and Forecast, by Treatment(2022-2029) 6.5.8.4. Vietnam Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.9. Taiwan 6.5.9.1. Taiwan Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.9.2. Taiwan Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.9.3. Taiwan Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.9.4. Taiwan Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 6.5.10.2. Rest of Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 6.5.10.3. Rest of Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 6.5.10.4. Rest of Asia Pacific Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 7. Middle East and Africa Companion Animal Arthritis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 7.2. Middle East and Africa Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 7.3. Middle East and Africa Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 7.4. Middle East and Africa Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 7.5. Middle East and Africa Companion Animal Arthritis Market Size and Forecast, by Country (2022-2029) 7.5.1. South Africa 7.5.1.1. South Africa Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 7.5.1.2. South Africa Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 7.5.1.3. South Africa Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 7.5.1.4. South Africa Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 7.5.2. GCC 7.5.2.1. GCC Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 7.5.2.2. GCC Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 7.5.2.3. GCC Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 7.5.2.4. GCC Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 7.5.3. Nigeria 7.5.3.1. Nigeria Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 7.5.3.2. Nigeria Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 7.5.3.3. Nigeria Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 7.5.3.4. Nigeria Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 7.5.4.2. Rest of ME&A Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 7.5.4.3. Rest of ME&A Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 7.5.4.4. Rest of ME&A Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 8. South America Companion Animal Arthritis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 8.2. South America Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 8.3. South America Companion Animal Arthritis Market Size and Forecast, by Treatment(2022-2029) 8.4. South America Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 8.5. South America Companion Animal Arthritis Market Size and Forecast, by Country (2022-2029) 8.5.1. Brazil 8.5.1.1. Brazil Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 8.5.1.2. Brazil Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 8.5.1.3. Brazil Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 8.5.1.4. Brazil Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 8.5.2. Argentina 8.5.2.1. Argentina Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 8.5.2.2. Argentina Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 8.5.2.3. Argentina Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 8.5.2.4. Argentina Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Companion Animal Arthritis Market Size and Forecast, by Animal Type (2022-2029) 8.5.3.2. Rest Of South America Companion Animal Arthritis Market Size and Forecast, by Type (2022-2029) 8.5.3.3. Rest Of South America Companion Animal Arthritis Market Size and Forecast, by Treatment (2022-2029) 8.5.3.4. Rest Of South America Companion Animal Arthritis Market Size and Forecast, by Distribution (2022-2029) 9. Global Companion Animal Arthritis Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Companion Animal Arthritis Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Virbac, 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Dechra Pharmaceuticals plc, 10.3. Vetoquinol Animal Health Pvt Ltd, 10.4. Phibro Animal Health Corp 10.5. Boehringer Ingelheim GmbH, 10.6. Bayer AG, 10.7. Ceva Sante Animale 10.8. Abbott Laboratories 10.9. Qiagen N.V. 10.10. Becton, Dickinson and Company 10.11. Quest Diagnostics, Inc. 10.12. Hologic, Inc. 10.13. F. Hoffmann-La Roche 10.14. Femasys, Inc. 10.15. Arbor Vita Corporation 10.16. NURX, Inc. 10.17. Seegene, Inc. 10.18. Thermo Fisher Scientific, Inc. 10.19. bioMérieux SA 11. Key Findings 12. Industry Recommendations 13. Companion Animal Arthritis Market: Research Methodology 14. Terms and Glossary